Two Sigma Advisers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,736,800
Closed -$12.5M 1484
2025
Q4
$12.5M Buy
1,736,800
+1,155,500
+199% +$9.13M 0.02% 474
2025
Q3
$6.21M Buy
581,300
+192,000
+49% +$1.88M 0.01% 660
2025
Q2
$3.77M Buy
+389,300
New +$4.02M 0.01% 845

Other funds holding OGN

Two Sigma Advisers's OGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 1,736,800 shares — an estimated $12.5M sold.

Two Sigma Advisers first reported a position in OGN in Q2 2025 and held it in 3 quarters. The position peaked at $12.5M in Q4 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,736,800 Organon & Co shares in Q1 2026, an estimated $12.5M.
  • Two Sigma Advisers first reported a position in Organon & Co in Q2 2025 and held it in 3 quarters.
  • Two Sigma Advisers's Organon & Co position peaked at $12.5M in Q4 2025.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.